Leveraging Automated Optimization of Inspired Oxygen and Oxidized Biomarker Lipidomics for Targeted Oxygenation during Mechanical Ventilation: a Pragmatic Clinical Trial
利用吸入氧和氧化生物标志物脂质组学的自动优化在机械通气期间进行靶向氧合:一项实用的临床试验
基本信息
- 批准号:10592000
- 负责人:
- 金额:$ 17.02万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-05-19 至 2027-04-30
- 项目状态:未结题
- 来源:
- 关键词:Active LearningAcute Lung InjuryAdverse effectsAdvisory CommitteesAffectAlgorithmsAutomobile DrivingBioinformaticsBiological MarkersBronchoalveolar Lavage FluidClinicalClinical ResearchClinical Trials DesignCluster randomized trialCognitiveCoupledCritical CareCritical IllnessDataDevelopmentDoctor of MedicineElectronic Health RecordElectronicsEnrollmentEnsureEnvironmentEventExclusionExposure toFundingFutureGoalsGuidelinesHealth PersonnelHourHyperoxiaHypoxemiaHypoxemic Respiratory FailureHypoxiaInjuryInterdisciplinary StudyInterventionKnowledgeLaboratory TechniciansLength of StayLifeLipid PeroxidationLipidsLungMass Spectrum AnalysisMeasuresMechanical ventilationMediatingMedicineMentorsMetabolic acidosisMulti-Institutional Clinical TrialOhioOmega-3 Fatty AcidsOrgan failureOutcomeOxidative Stress InductionOxygenOxygen Therapy CarePatient-Focused OutcomesPatientsPeripheralPersonsPhysiciansPhysiologicalPilot ProjectsPopulationPragmatic clinical trialPreventionProtocols documentationQuality of lifeQuestionnairesRandomizedRecording of previous eventsResearchResearch PersonnelResourcesRespiratory FailureRiceSafetyScientistSleepSonalSupplementationSurvivorsTelephoneTherapeuticTimeTissue PreservationTissuesTitrationsToxic effectTrainingTranslational ResearchUniversitiesUnsaturated Fatty AcidsVariantVentilatorbiomarker identificationcardiovascular collapsecareercareer developmentcell injurycognitive functiondesignefficacy evaluationfollow-uphyperoxia induced lung injuryimprovedimproved outcomeinnovationinterestlipidomicslung failurelung injurymortalitynoveloxidized lipidoxygen toxicitypatient populationperoxidationpreventprimary outcomesecondary outcomeskillsstatisticssupplemental oxygentissue oxygenationtooltranslational approachtranslational scientisttreatment as usual
项目摘要
PROJECT SUMMARY:
Candidate: The candidate, Sonal Pannu, M.D. is an early career investigator from the division of Pulmonary,
Critical Care, and Sleep Medicine at the Ohio State University and has an excellent academic track record. She
has demonstrated persistent interest in clinical and translational research for improving the safety of mechanical
ventilation, focusing on prevention of hyperoxia and hypoxemia. In addition, she has developed bioinformatics
related electronic algorithms for targeted oxygenation and is using oxidized lipidomics biomarkers to determine
optimal oxygenation targets. Her short-term goal is to augment the clinical researchtraining with advanced
training in pragmatic and novel clinical trial design, bioinformatics and associated statistics for development of
lipidomics biomarkers. Her long term goal is to become a successful independent clinical and translational
scientist leading a multidisciplinary research team focused on pragmatic clinical trials in the ICU for utilizing
lipidomics biomarkers for ascertainment of optimal oxygenation to improve outcomes of critically ill patients.
Career Development: Dr. Pannu’s career development will include plans enroll in formal training for conducting
pragmatic multi-center clinical trials; in lipidomics; in bioinformatics and associated statistics through didactics
and experiential learning. Environment: Dr. Pannu is currently in an environment that is extremely supportive
for her development as a clinical and translational researcher. There is a large ICU patient population
and support in the form of resources for clinical research, bioinformatics, clinical coordinators and laboratory
technicians. Dr. Pannu’smentors, Dr. Crouser (Ohio State University), Dr. Diaz (Ohio State University) and Dr.
Rice (Vanderbilt) have an outstanding history as mentors in addition her research advisory committee consists
of well-funded and accomplished researchers. Research: Dr. Pannu’s goal in this project is to study
an approach to targeted oxygenation goals through an automated oxygen titration strategy. Her specific aims
are: Aim 1: Determine the efficacy of an electronic health record based oxygen-titration strategy to
maintain arterial oxygen saturation validated, optimized targeted peripheral oxygen saturation range
and Aim 2: Analyze oxidized lipid biomarkers as markers of hyperoxia associated lung injury in
patients with the optimized targeted oxygenation strategy compared with usual care. To accomplish
this Dr. Pannu will conduct a pragmatic clinical trial with cluster randomization, stepped wedge
design to study targeted oxygenation with an automated protocol vs conventional approach by ventilator
management guidelines. She will assess short term (ventilator and ICU based) and long term clinical outcomes
(6 month follow up for cognitive function assessment). She will also measure and compare oxidized lipid
biomarkers within the two groups to determine the oxidized biomarker profile for optimal oxygenation and
correlate their expression to the degree ofoxygen exposure and ventilator-free days.
项目概要:
候选人:候选人,Sonal Pannu,医学博士。是肺科的早期职业调查员
重症监护和睡眠医学在俄亥俄州州立大学,并有一个良好的学术记录。她
已经表现出对临床和转化研究的持续兴趣,以提高机械安全性,
通气,重点预防高氧和低氧血症。此外,她还开发了生物信息学
相关的电子算法的靶向氧合,并使用氧化脂质组学生物标志物,以确定
最佳氧合目标。她的短期目标是用先进的
培训实用和新颖的临床试验设计,生物信息学和相关统计学,以开发
脂质组学生物标志物。她的长期目标是成为一个成功的独立的临床和翻译
一位科学家领导一个多学科研究小组,专注于在ICU进行实用的临床试验,
脂质组学生物标志物用于确定最佳氧合,以改善危重患者的结局。
职业发展:Pannu博士的职业发展将包括参加正式培训,
实用的多中心临床试验;在脂质组学;在生物信息学和相关统计学通过教学法
和体验式学习。环境:Pannu博士目前处于非常支持的环境中
作为一名临床和翻译研究人员的发展。ICU患者人数众多
并以临床研究、生物信息学、临床协调员和实验室资源的形式提供支持
专业人帕努博士的导师,克劳泽博士(俄亥俄州州立大学),迪亚兹博士(俄亥俄州州立大学)和博士。
赖斯(范德比尔特)有一个杰出的历史,除了她的研究顾问委员会组成的导师
资金充足且有成就的研究人员研究:Pannu博士在这个项目中的目标是研究
通过自动氧滴定策略实现目标氧合目标的方法。她的具体目标
目标1:确定基于电子健康记录的氧滴定策略的功效,
维持经验证的动脉血氧饱和度,优化目标外周血氧饱和度范围
目的2:分析氧化脂质生物标志物作为高氧相关肺损伤的标志物,
与常规护理相比,优化靶向氧合策略的患者。完成
这位Pannu博士将进行一项实用的临床试验,
旨在研究自动化方案与呼吸机常规方法的靶向氧合
管理方针。她将评估短期(基于呼吸机和ICU)和长期临床结局
(6个月随访进行认知功能评估)。她还将测量和比较氧化脂质
两组内的生物标志物,以确定最佳氧合的氧化生物标志物谱,
将它们的表达与氧暴露程度和无呼吸机天数相关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Sonal R. Pannu其他文献
Sonal R. Pannu的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 17.02万 - 项目类别: